The global Immunoassay Market by Product (Reagents & Kits, Analyzers), Technology (ELISA, Rapid Test, Western Blotting, ELISPOT), Specimen (Blood, Saliva), Application (Infectious Diseases, Oncology), End User (Hospitals & Clinics) – Global Forecasts to 2027,” is expected to reach USD 49.6 billion by 2027, with a CAGR of 4.3% during the forecast period. The market growth is driven by factors such as the increasing prevalence of chronic and infectious diseases, adoption of immunoassay-based point-of-care and rapid testing, and strict regulations mandating drug and alcohol testing. Growth opportunities in emerging economies and the development of condition-specific biomarkers and tests also contribute to the market’s potential.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=436
In terms of product segments, reagents & kits hold the largest share in the immunoassay market, driven by high consumption and repeat purchases, along with an increasing number of immunoassay tests performed globally.
Among the technology segments, rapid tests are expected to register the highest growth rate during the forecast period. Rapid tests play a crucial role in point-of-care diagnosis, particularly in emergency and primary care settings, enabling the screening of HIV, HCV, HBV, and HCG antibodies in donated blood.
Blood specimens accounted for the largest share in the immunoassay market based on specimen types. This can be attributed to the rising incidence of chronic and infectious diseases, as well as the increasing rate of blood donations.
In terms of applications, the infectious diseases segment is projected to have the highest growth rate during the forecast period. With the introduction of new products for infectious disease diagnosis, this segment is expected to witness significant development.
Hospitals and clinics are the largest end users of the immunoassay market. The prevalence of chronic and infectious diseases, coupled with the availability of advanced technologies, has contributed to the substantial growth of this segment. It is also expected to register the highest growth rate during the forecast period.
North America is the largest regional market for immunoassay, driven by the increasing prevalence of chronic diseases, a growing geriatric population, the presence of leading national clinical laboratories, and easy accessibility to technologically advanced instruments.
Get 10% Customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=436
Prominent players in the immunoassay market include Abbott Laboratories, F. Hoffmann-La Roche, and Siemens Healthineers.
Related links:
https://www.marketsandmarkets.com/Market-Reports/immunoassay-market-436.html
https://www.marketsandmarkets.com/PressReleases/immunoassay.asp
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
